McCormick & Co., Inc (MKC) concluded trading on Thursday at a closing price of $77.57, with 4.69 million shares of worth about $363.54 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -1.64% during that period and on June 26, 2025 the price saw a gain of about 5.34%. Currently the company’s common shares owned by public are about 268.19M shares, out of which, 252.16M shares are available for trading.
Stock saw a price change of 5.97% in past 5 days and over the past one month there was a price change of 8.04%. Year-to-date (YTD), MKC shares are showing a performance of 12.10% which increased to 1.74% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $66.88 but also hit the highest price of $86.24 during that period. The average intraday trading volume for McCormick & Co., Inc shares is 2.35 million. The stock is currently trading 4.64% above its 20-day simple moving average (SMA20), while that difference is up 4.24% for SMA50 and it goes to -0.28% lower than SMA200.
McCormick & Co., Inc (NYSE: MKC) currently have 268.19M outstanding shares and institutions hold larger chunk of about 83.76% of that.
The stock has a current market capitalization of $20.80B and its 3Y-monthly beta is at 0.68. PE ratio of stock for trailing 12 months is 26.93, while it has posted earnings per share of $2.88 in the same period. Its PEG reads 4.11 and has Quick Ratio of 0.27 while making debt-to-equity ratio of 0.80. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for MKC, volatility over the week remained 2.02% while standing at 1.92% over the month.
Stock’s fiscal year EPS is expected to rise by 2.41% while it is estimated to increase by 8.96% in next year. EPS is likely to grow at an annualized rate of 6.55% for next 5-years, compared to annual growth of 2.22% made by the stock over the past 5-years.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by UBS on June 16, 2025 offering a Neutral rating for the stock and assigned a target price of $83 to it. On January 08, 2025, TD Cowen Upgrade their recommendations, while on December 09, 2024, Jefferies Upgrade their ratings for the stock with a price target of $91. Stock get a Neutral rating from Citigroup on June 12, 2024.
